Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis

NeuroReport

Volumn 10, Issue 2, 1999, Pages 399-402

  Macchi, Beatrice ^a,b   Matteucci, Claudia ^a   Nocentini, Ugo ^a,b   Caltagirone, Carlo ^a,b   Mastino, Antonio ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

Activation induced cell death; Apoptosis; Bcl 2; Demyelination; Fas; Multiple sclerosis; PHA

Indexed keywords

FAS ANTIGEN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MALE; MITOGENESIS; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0033525162     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199902050-00034     Document Type: Article

References (25)

1. De Maria R and Testi R. Immunol Today 19, 121-125 (1997).
2. Suda T and Nagata S. J Allergy Clin Immunol 100, 97-101 (1997).
3. Brosnan CF and Raine C. Brain Pathol 6, 243-257 (1996).
4. Martin R, Jaraquemada D, Flerlage M et al. J Immunol 145, 540-548 (1990).
5. Dowling P, Shang G, Raval S et al. J Exp Med 184, 1513-1518 (1996).
6. D'Souza SD, Bonetti B, Balasingman V et al. J Exp Med 184, 2361-2370 (1996).
7. Bonetti B and Raine CS. Ann Neurol 42, 74-84 (1997).
8. Bansil S, Holtz CR, Cook SD and Rohowsky-Kochan C. Acta Neurol Scand 95, 208-210 (1997).
9. Zipp F, Weller M, Calabresi PA et al. Ann Neurol 43, 116-120 (1998).
10. Ferrante P, Fusi ML, Saresella M et al. J Immunol 160, 1514-1521 (1998).
11. Ciusani E, Frigerio S, Gelati M et al. J Neuroimmunol 82, 5-12 (1998).
12. Matiba B, Mariani SM and Krammer PH. Semin Immunol 9, 59-68 (1997).
13. Wesch D, Marx S and Kabelitz D. J Immunol 161, 1248-1256 (1998).
14. Poser CM, Paty DW, Scheinberg L et al. Ann Neurol 13, 227-231 (1983).
15. Mastino A, Sciortino MT, Medici MA et al. Cell Death Differ 4, 629-638 (1997).
16. Zipp F, Martin R, Lichtenfels R et al. J Immunol 159, 2108-2115 (1997).
17. Zipp F, Faber E, Sommer N et al. J Neuroimmunol 81, 168-172 (1998).
18. Ichikawa H, Ota K and Iwata M. J Neuroimmunol 71, 125-129 (1996).
19. Kovacs B, Vassilopoulos D, Vogelgesang SA and Tsokos GC. Clin Immunol Immunopathol 81, 293-302 (1996).
20. Nagata S and Suda T. Fas and Fas ligand: lpr and gld mutations Immunol Today 16, 243-257 (1995).
21. Sabelko K, Kelly KA, Nahm MH et al. J Immunol 159, 3096-3099 (1997).
22. Waldner H, Sobel RA, Howard E et al. J Immunol 159, 3100-3103 (1997).
23. Martino G, Grohovaz F, Brambilla E et al. Ann Neurol 43, 340-349 (1998).
24. Tanaka M, Itai T, Adachi M and Nagata S. Nature Med 4, 31-36 (1998).
25. Zipp F, Otzelberger K, Dichgans J et al. Neuroimmunology 86, 151-154 (1998).